N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate; N,N-Diethyl-3-phenyl-1,2,4-oxadiazole-5-ethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 5-[2-(diethylamino)ethyl]-3-phenyl-1,2,4-oxadiazole Citrate (1:1); 3-Phenyl-5-(diethylaminoethyl)-1,2,4-oxadiazole Citrate; 5-(Diethylaminoethyl)-3-phenyl-1,2,4-oxadiazole Citrate; AF 438; Bredon; Broncatar; Flogobron; NSC 100298; Oxarmin; Perebron; Prilon; SKF 9976
Oxolamine Citrate is a fully characterized chemical compound used as a reference standard of API Oxolamine. The standard offered is compliant with regulatory guidelines. Oxolamine Citrate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1949-20-8
